A Phase 1 First in Human, Multicentre, Open-Label Study to Determine the Safety, Tolerability, Pharmacokinetics, and Recommended Phase 2 Dose of CCX559 in Subjects with Solid Tumors [CL001_559]
- Richardson, Gary (Primary Chief Investigator (PCI))
- Lai, Li Hoon (Project Manager)
Project: Research